This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Sagent Pharmaceuticals And The Chicago Innovation Awards To Ring NASDAQ

Stocks in this article: SGNT

SCHAUMBURG, Ill., March 31, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) will join the Chicago Innovation Awards, the Chicago region's foremost annual celebration of innovation, in New York City on Monday, March 31, to close the NASDAQ Stock Market, the premier exchange for technology companies. The event, arranged by the Chicago Innovation Awards, will emphasize the surge of innovation that is occurring in the Chicago region and shine a spotlight on the organizations that make up its vibrant economy.

Sagent's Heparin Product Family
Sagent's Heparin Product Family

"This annual event is an excellent example of how the Chicago Innovation Awards celebrate the spirit of innovation in organizations across all industries, sizes and sectors," said Tom Kuczmarski, Co-Founder of the Chicago Innovation Awards.

"We congratulate Sagent Pharmaceuticals for winning the Chicago Innovation Awards, and applaud their commitment to innovation," said Dan Miller, fellow Co-Founder. Joining Sagent Pharmaceuticals will be fellow winners of the 2013 Chicago Innovation Awards including Anova Technologies, Autonomy Works, Belly, Braintree, Chicago Public Library, Everpurse, FarmedHere, FarmLogix, First Alert, iLight Technologies, Ingenuity, Life Spine, Moxie Jean, Nordic Auto Plow, Portapure, Protein Bar, Rabine Group, SceneTap, SimpleRelevance, SiNode Systems, SwipeSense and tastytrade.

"We are delighted to be recognized by the Chicago Innovation Awards and we'd also like to salute our fellow winners. When fewer than three percent of nominees from an extremely competitive field are chosen as award winners, you know you are in very good company," said Jeffrey M. Yordon, Chief Executive Officer and Chairman of the Board of Sagent. "For us, having an independent third party acknowledge the importance of our innovation to patients and caregivers throughout the United States is both humbling and gratifying. We continue to work tirelessly to advance patient safety and are also spreading the word to encourage others to strive to help reduce the risk of medication errors."

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,371.89 -306.81 -1.74%
S&P 500 2,033.09 -24.00 -1.17%
NASDAQ 4,699.3810 -72.3820 -1.52%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs